These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7669637)

  • 1. p53 protein expression in cutaneous T-cell lymphomas.
    Lauritzen AF; Vejlsgaard GL; Hou-Jensen K; Ralfkiaer E
    Br J Dermatol; 1995 Jul; 133(1):32-6. PubMed ID: 7669637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 oncoprotein expression in cutaneous lymphoproliferations.
    Beylot-Barry M; Vergier B; DeMascarel A; Beylot C; Merlio JP
    Arch Dermatol; 1995 Sep; 131(9):1019-24. PubMed ID: 7661603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH; Olson LC; Magro CM
    Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 immunoreactivity is uncommon in primary cutaneous lymphoma.
    McGregor JM; Dublin EA; Levison DA; MacDonald DM; Smith NP; Whittaker S
    Br J Dermatol; 1995 Mar; 132(3):353-8. PubMed ID: 7718450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cancer/testis antigens in cutaneous T cell lymphomas.
    Häffner AC; Tassis A; Zepter K; Storz M; Tureci O; Burg G; Nestle FO
    Int J Cancer; 2002 Feb; 97(5):668-70. PubMed ID: 11807795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and bcl-2 expression do not correlate with prognosis in primary cutaneous large T-cell lymphomas.
    van Haselen CW; Vermeer MH; Toonstra J; van der Putte SC; Mulder PG; van Vloten WA; Willemze R
    J Cutan Pathol; 1997 Sep; 24(8):462-7. PubMed ID: 9331891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus.
    Kanavaros P; Ioannidou D; Tzardi M; Datseris G; Katsantonis J; Delidis G; Tosca A
    Pathol Res Pract; 1994 Sep; 190(8):767-74. PubMed ID: 7831152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment in mycosis fungoides and Sézary syndrome.
    Rubio Gonzalez B; Zain J; Rosen ST; Querfeld C
    Curr Opin Oncol; 2016 Jan; 28(1):88-96. PubMed ID: 26632770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.
    Wu J; Nihal M; Siddiqui J; Vonderheid EC; Wood GS
    J Invest Dermatol; 2009 May; 129(5):1165-73. PubMed ID: 18923451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative analysis of the expression of cell adhesion molecules in cutaneous T-cell lymphomas (mycosis fungoides/Sézary syndrome) and inflammatory skin diseases].
    López-Lerma I; Estrach MT
    Actas Dermosifiliogr; 2010 Dec; 101(10):866-77. PubMed ID: 21159263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-7 receptor expression in cutaneous T-cell lymphomas.
    Bagot M; Charue D; Boulland ML; Gaulard P; Revuz J; Schmitt C; Wechsler J
    Br J Dermatol; 1996 Oct; 135(4):572-5. PubMed ID: 8915148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequent expression of protein p53 in epidermotropic variants of cutaneous T-cell lymphoma.
    de Misa RF; Azaña JM; Harto A; Bellas C; Ledo A
    J Dermatol; 1995 Jul; 22(7):524-6. PubMed ID: 7560447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
    Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
    Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of cutaneous lymphomas.
    Stadler R; Stranzenbach R
    Exp Dermatol; 2018 Oct; 27(10):1078-1083. PubMed ID: 29862563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas.
    Urosevic M; Willers J; Mueller B; Kempf W; Burg G; Dummer R
    Blood; 2002 Jan; 99(2):609-17. PubMed ID: 11781245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Granulysin and FOXP3 in Cutaneous T Cell Lymphoma and Sézary Syndrome.
    Shareef MM; Elgarhy LH; Wasfy Rel-S
    Asian Pac J Cancer Prev; 2015; 16(13):5359-64. PubMed ID: 26225678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.